文献速递细胞病理与分子病理神经与头颈病理

PRKD1 E710D热点突变在细针穿刺中高特异性区分腭部多形性腺癌与腺样囊性癌及多形性腺瘤

The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA.
PubMed 文献 · Cancer Cytopathol · 2017-12-20

该研究对18例多形性腺癌(PAC)、25例腺样囊性癌(ACC)和21例多形性腺瘤(PA)的配对细针穿刺(FNA)和手术标本进行PRKD1外显子15(含E710D热点)测序。约50%的PAC病例在FNA和手术标本中均检测到相同的PRKD1 E710D热点突变,而ACC和PA均无该热点突变。PRKD1热点突变识别PAC的特异性为100%,敏感性为50%。

要点

  • PRKD1 E710D热点突变在FNA中识别PAC的特异性为100%,敏感性为50%。
  • ACC中出现的PRKD1其他位点突变可排除PAC,更提示ACC。
  • PA病例未检测到PRKD1突变,有助于与PAC鉴别。

核心结论

  • PRKD1 E710D热点突变在FNA标本中识别PAC具有高度特异性,但敏感性中等。
  • PRKD1非热点突变可排除PAC,更提示ACC。

研究设计与样本

  • 收集18例PAC、25例ACC和21例PA的配对May-Grunwald-Giemsa染色FNA和相应手术标本。
  • 对PRKD1外显子15(含E710D热点)进行双脱氧核苷酸测序。

主要发现

  • 约50%的PAC病例在FNA和手术标本中均检测到相同的PRKD1 E710D热点突变。
  • 2例ACC标本在FNA和手术标本中均检测到测序区域内的点突变,但均不在热点区域。
  • 所有PA病例均未检测到PRKD1突变。
  • PRKD1热点突变识别PAC的特异性为100%,敏感性为50%。

关键数值与推荐

  • PRKD1热点突变识别PAC的敏感性为50%,特异性为100%。
  • ACC中出现的PRKD1非热点突变可排除PAC,更提示ACC。

临床怎么用

  • 对腭部小唾液腺肿瘤的FNA标本可进行PRKD1 E710D热点测序,阳性高度提示PAC。
  • PRKD1热点突变阴性不能排除PAC,需结合细胞形态学。
  • 检测到PRKD1非热点突变时更倾向于ACC而非PAC。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polymorphous adenocarcinoma (PAC) of the palatal minor salivary glands, previously known as polymorphous low-grade adenocarcinoma, is the second most common intraoral malignant salivary gland carcinoma after adenoid cystic carcinoma (ACC) and carries an excellent prognosis. Unfortunately, PAC demonstrates cytological overlap with 2 other salivary gland tumors frequently encountered in the same location, namely ACC and pleomorphic adenoma (PA). Recently, the protein kinase D1 (PRKD1) hotspot mutation E710D was demonstrated to be specific for PAC and to be present in the majority of cases. The objective of the current study was to investigate the value of PRKD1 hotspot sequencing in identifying PAC in paired fine-needle aspiration (FNA) and surgical specimens from cases of PAC, ACC, and PA. METHODS: Paired May-Grunwald-Giemsa-stained FNA and corresponding surgical specimens were collected from 18 PAC cases, 25 ACC cases, and 21 PA cases. Both sets of specimens were subjected to dideoxynucleotide sequencing of PRKD1 exon 15, including the PRKD1 E710D hotspot. RESULTS: Of the PAC cases, approximately 50% demonstrated identical PRKD1 E710D hotspot mutations on the FNA specimen and corresponding surgical specimen. Two ACC specimens had point mutations within the sequenced region in the FNA specimen as well as the surgical specimen, but none were located in the hotspot region. None of the PA cases demonstrated PRKD1 mutations. The specificity of the PRKD1 hotspot mutation for identifying PAC among ACC and PA cases was 100% whereas the sensitivity was 50%. CONCLUSIONS: The PRKD1 E710D hotspot mutation is highly specific for identifying PAC on FNA among cases of ACC and PA, whereas the sensitivity is only modest. Alternative PRKD1 mutations exclude PAC, and are more suggestive of ACC. Cancer Cytopathol 2018;126:275-81. © 2017 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Andreasen S, Melchior LC, Kiss K, et al. The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA. Cancer Cytopathol. 2017. PMID: 29266837. doi:10.1002/cncy.21959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。